198 related articles for article (PubMed ID: 32279227)
1. Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.
Rinaldi F; Trink A; Pinto D
Dermatol Ther (Heidelb); 2020 Jun; 10(3):483-493. PubMed ID: 32279227
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata.
Rinaldi F; Marzani B; Pinto D; Sorbellini E
J Dermatolog Treat; 2019 Sep; 30(6):588-593. PubMed ID: 30513014
[No Abstract] [Full Text] [Related]
3. A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp.
Hegde P; Relhan V; Sahoo B; Garg VK
Dermatol Ther; 2020 Nov; 33(6):e14388. PubMed ID: 33034942
[TBL] [Abstract][Full Text] [Related]
4. Growth factor concentrations in platelet-rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo-controlled, pilot study.
Siah TW; Guo H; Chu T; Santos L; Nakamura H; Leung G; Shapiro J; McElwee KJ
Exp Dermatol; 2020 Mar; 29(3):334-340. PubMed ID: 31984508
[TBL] [Abstract][Full Text] [Related]
5. A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia.
Gentile P; Dionisi L; Pizzicannella J; de Angelis B; de Fazio D; Garcovich S
Expert Opin Biol Ther; 2020 Sep; 20(9):1099-1109. PubMed ID: 32678725
[TBL] [Abstract][Full Text] [Related]
6. Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia.
Gentile P; Garcovich S
Expert Opin Biol Ther; 2020 Mar; 20(3):327-337. PubMed ID: 32011196
[No Abstract] [Full Text] [Related]
7. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Trink A; Sorbellini E; Bezzola P; Rodella L; Rezzani R; Ramot Y; Rinaldi F
Br J Dermatol; 2013 Sep; 169(3):690-4. PubMed ID: 23607773
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) on Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB-Approved Study.
Sasaki GH
Aesthet Surg J; 2021 Oct; 41(11):NP1659-NP1672. PubMed ID: 34050738
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of Therapeutic Efficacy of Intralesional Injection of Triamcinolone Acetonide versus Intralesional Autologous Platelet-rich Plasma Injection in Alopecia Areata.
Kapoor P; Kumar S; Brar BK; Kukar N; Arora H; Brar SK
J Cutan Aesthet Surg; 2020; 13(2):103-111. PubMed ID: 32792771
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
Gentile P; Garcovich S; Bielli A; Scioli MG; Orlandi A; Cervelli V
Stem Cells Transl Med; 2015 Nov; 4(11):1317-23. PubMed ID: 26400925
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Therapeutic Response to Intralesional Injections of Platelet-Rich Plasma Versus Triamcinolone Acetonide in Alopecia Areata.
Balakrishnan A; Joy B; Thyvalappil A; Mathew P; Sreenivasan A; Sridharan R
Indian Dermatol Online J; 2020; 11(6):920-924. PubMed ID: 33344340
[TBL] [Abstract][Full Text] [Related]
12. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
Almutairi N; Nour TM; Hussain NH
Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
[TBL] [Abstract][Full Text] [Related]
13. Trichoscopy as an evaluation method for alopecia areata treatment: A comparative study.
Fawzy MM; Abdel Hay R; Mohammed FN; Sayed KS; Ghanem MED; Ezzat M
J Cosmet Dermatol; 2021 Jun; 20(6):1827-1836. PubMed ID: 32991045
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata.
Albalat W; Ebrahim HM
J Cosmet Dermatol; 2019 Oct; 18(5):1456-1462. PubMed ID: 31074201
[TBL] [Abstract][Full Text] [Related]
16. Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling.
Ragab SEM; Nassar SO; Morad HA; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Dec; 29(4):169-173. PubMed ID: 33348935
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia.
Ince B; Yildirim MEC; Dadaci M; Avunduk MC; Savaci N
Aesthetic Plast Surg; 2018 Feb; 42(1):297-303. PubMed ID: 29101437
[TBL] [Abstract][Full Text] [Related]
18. Alopecia and platelet-derived therapies.
Cole JP; Cole MA; Insalaco C; Cervelli V; Gentile P
Stem Cell Investig; 2017; 4():88. PubMed ID: 29270414
[TBL] [Abstract][Full Text] [Related]
19. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
Eisman S; Sinclair R
Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
[TBL] [Abstract][Full Text] [Related]
20. The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trial.
Rafati M; Mahmoudian R; Golpour M; Kazeminejad A; Saeedi M; Nekoukar Z
Dermatol Ther; 2022 Jun; 35(6):e15450. PubMed ID: 35289043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
